HEADER TRANSFERASE 28-JUN-14 4TVY TITLE APO RESORUFIN LIGASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPOATE-PROTEIN LIGASE A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: LIPOATE--PROTEIN LIGASE; COMPND 5 EC: 2.7.7.63; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: LPLA, YJJF, B4386, JW4349; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E. COLI LPLA, COMPUTATIONAL ENZYME DESIGN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.J.GOLDMAN,C.L.DRENNAN REVDAT 6 27-SEP-23 4TVY 1 REMARK REVDAT 5 20-NOV-19 4TVY 1 REMARK REVDAT 4 22-NOV-17 4TVY 1 REMARK REVDAT 3 13-SEP-17 4TVY 1 SOURCE JRNL REMARK REVDAT 2 05-NOV-14 4TVY 1 JRNL REVDAT 1 22-OCT-14 4TVY 0 JRNL AUTH D.S.LIU,L.G.NIVON,F.RICHTER,P.J.GOLDMAN,T.J.DEERINCK, JRNL AUTH 2 J.Z.YAO,D.RICHARDSON,W.S.PHIPPS,A.Z.YE,M.H.ELLISMAN, JRNL AUTH 3 C.L.DRENNAN,D.BAKER,A.Y.TING JRNL TITL COMPUTATIONAL DESIGN OF A RED FLUOROPHORE LIGASE FOR JRNL TITL 2 SITE-SPECIFIC PROTEIN LABELING IN LIVING CELLS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 111 E4551 2014 JRNL REFN ESSN 1091-6490 JRNL PMID 25313043 JRNL DOI 10.1073/PNAS.1404736111 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 42497 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.9853 - 5.3019 0.98 2830 155 0.1889 0.2296 REMARK 3 2 5.3019 - 4.2092 0.99 2777 145 0.1693 0.2316 REMARK 3 3 4.2092 - 3.6774 0.99 2706 146 0.1872 0.2056 REMARK 3 4 3.6774 - 3.3413 1.00 2715 142 0.2037 0.2494 REMARK 3 5 3.3413 - 3.1019 0.99 2701 132 0.2210 0.2646 REMARK 3 6 3.1019 - 2.9191 0.99 2719 132 0.2367 0.2950 REMARK 3 7 2.9191 - 2.7729 1.00 2711 124 0.2441 0.3011 REMARK 3 8 2.7729 - 2.6522 1.00 2695 120 0.2357 0.2949 REMARK 3 9 2.6522 - 2.5501 1.00 2701 142 0.2485 0.3048 REMARK 3 10 2.5501 - 2.4621 0.99 2648 168 0.2581 0.3428 REMARK 3 11 2.4621 - 2.3851 1.00 2632 180 0.2601 0.3181 REMARK 3 12 2.3851 - 2.3170 1.00 2653 150 0.2645 0.3294 REMARK 3 13 2.3170 - 2.2560 1.00 2684 138 0.2659 0.3017 REMARK 3 14 2.2560 - 2.2009 0.99 2663 131 0.2679 0.3326 REMARK 3 15 2.2009 - 2.1509 0.93 2518 139 0.2882 0.3591 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.650 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.63 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5335 REMARK 3 ANGLE : 1.033 7243 REMARK 3 CHIRALITY : 0.062 779 REMARK 3 PLANARITY : 0.004 948 REMARK 3 DIHEDRAL : 15.855 1927 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TVY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000202375. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42531 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 44.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.54100 REMARK 200 FOR SHELL : 2.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1X2G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 UL OF 5.6 MG/ML RESORUFIN LIGASE REMARK 280 CONTAINING 1 MM RESORUFIN SULFAMOYLADENOSINE, 1 MM MG(OAC)2, AND REMARK 280 1 MM DITHIOTHREITOL MIXED WITH 2 UL OF PRECIPITANT SOLUTION (11% REMARK 280 PEG 20,000, 0.15 M MES:NAOH, PH 6.5). RED COLORED CRYSTALLINE REMARK 280 PLATES APPEARED AFTER ~ 5 DAYS. CRYSTALS WERE LOOPED AND WASHED REMARK 280 THROUGH A CRYOPROTECTION SOLUTION OF 80% PRECIPITANT SOLUTION REMARK 280 (12% PEG 20,000, 0.2 M MES:NAOH, PH 6.5) AND 20% GLYCEROL. REMARK 280 CRYSTALS WERE THEN CRYOCOOLED BY DIRECTION SUBMERSION INTO REMARK 280 LIQUID NITROGEN., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.55850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.44500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.97550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.44500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.55850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.97550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 LYS A 175 REMARK 465 GLY A 176 REMARK 465 ILE A 177 REMARK 465 THR A 178 REMARK 465 SER A 179 REMARK 465 VAL A 180 REMARK 465 ARG A 181 REMARK 465 SER A 182 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 PRO B 167 REMARK 465 ASP B 168 REMARK 465 LYS B 169 REMARK 465 LYS B 170 REMARK 465 LYS B 171 REMARK 465 LEU B 172 REMARK 465 ALA B 173 REMARK 465 ALA B 174 REMARK 465 LYS B 175 REMARK 465 GLY B 176 REMARK 465 ILE B 177 REMARK 465 THR B 178 REMARK 465 SER B 179 REMARK 465 VAL B 180 REMARK 465 ARG B 181 REMARK 465 SER B 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 155 54.83 -151.98 REMARK 500 ARG A 277 148.29 -171.69 REMARK 500 ASN B 223 1.78 -66.20 REMARK 500 LYS B 224 85.84 -159.36 REMARK 500 ARG B 277 148.17 -170.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 37R A 402 REMARK 610 37R B 401 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37R A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37R A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37R B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37R B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4TVW RELATED DB: PDB REMARK 900 4TVW CONTAINS THE SAME PROTEIN IN A CATALYTIC CONFORMATION REMARK 900 RELATED ID: 3A7R RELATED DB: PDB DBREF 4TVY A 0 337 UNP P32099 LPLA_ECOLI 1 338 DBREF 4TVY B 0 337 UNP P32099 LPLA_ECOLI 1 338 SEQADV 4TVY GLY A -3 UNP P32099 EXPRESSION TAG SEQADV 4TVY SER A -2 UNP P32099 EXPRESSION TAG SEQADV 4TVY HIS A -1 UNP P32099 EXPRESSION TAG SEQADV 4TVY ALA A 20 UNP P32099 GLU 21 ENGINEERED MUTATION SEQADV 4TVY ALA A 147 UNP P32099 PHE 148 ENGINEERED MUTATION SEQADV 4TVY GLY A 149 UNP P32099 HIS 150 ENGINEERED MUTATION SEQADV 4TVY GLY B -3 UNP P32099 EXPRESSION TAG SEQADV 4TVY SER B -2 UNP P32099 EXPRESSION TAG SEQADV 4TVY HIS B -1 UNP P32099 EXPRESSION TAG SEQADV 4TVY ALA B 20 UNP P32099 GLU 21 ENGINEERED MUTATION SEQADV 4TVY ALA B 147 UNP P32099 PHE 148 ENGINEERED MUTATION SEQADV 4TVY GLY B 149 UNP P32099 HIS 150 ENGINEERED MUTATION SEQRES 1 A 341 GLY SER HIS MET SER THR LEU ARG LEU LEU ILE SER ASP SEQRES 2 A 341 SER TYR ASP PRO TRP PHE ASN LEU ALA VAL ALA GLU CYS SEQRES 3 A 341 ILE PHE ARG GLN MET PRO ALA THR GLN ARG VAL LEU PHE SEQRES 4 A 341 LEU TRP ARG ASN ALA ASP THR VAL VAL ILE GLY ARG ALA SEQRES 5 A 341 GLN ASN PRO TRP LYS GLU CYS ASN THR ARG ARG MET GLU SEQRES 6 A 341 GLU ASP ASN VAL ARG LEU ALA ARG ARG SER SER GLY GLY SEQRES 7 A 341 GLY ALA VAL PHE HIS ASP LEU GLY ASN THR CYS PHE THR SEQRES 8 A 341 PHE MET ALA GLY LYS PRO GLU TYR ASP LYS THR ILE SER SEQRES 9 A 341 THR SER ILE VAL LEU ASN ALA LEU ASN ALA LEU GLY VAL SEQRES 10 A 341 SER ALA GLU ALA SER GLY ARG ASN ASP LEU VAL VAL LYS SEQRES 11 A 341 THR VAL GLU GLY ASP ARG LYS VAL SER GLY SER ALA TYR SEQRES 12 A 341 ARG GLU THR LYS ASP ARG GLY ALA HIS GLY GLY THR LEU SEQRES 13 A 341 LEU LEU ASN ALA ASP LEU SER ARG LEU ALA ASN TYR LEU SEQRES 14 A 341 ASN PRO ASP LYS LYS LYS LEU ALA ALA LYS GLY ILE THR SEQRES 15 A 341 SER VAL ARG SER ARG VAL THR ASN LEU THR GLU LEU LEU SEQRES 16 A 341 PRO GLY ILE THR HIS GLU GLN VAL CYS GLU ALA ILE THR SEQRES 17 A 341 GLU ALA PHE PHE ALA HIS TYR GLY GLU ARG VAL GLU ALA SEQRES 18 A 341 GLU ILE ILE SER PRO ASN LYS THR PRO ASP LEU PRO ASN SEQRES 19 A 341 PHE ALA GLU THR PHE ALA ARG GLN SER SER TRP GLU TRP SEQRES 20 A 341 ASN PHE GLY GLN ALA PRO ALA PHE SER HIS LEU LEU ASP SEQRES 21 A 341 GLU ARG PHE THR TRP GLY GLY VAL GLU LEU HIS PHE ASP SEQRES 22 A 341 VAL GLU LYS GLY HIS ILE THR ARG ALA GLN VAL PHE THR SEQRES 23 A 341 ASP SER LEU ASN PRO ALA PRO LEU GLU ALA LEU ALA GLY SEQRES 24 A 341 ARG LEU GLN GLY CYS LEU TYR ARG ALA ASP MET LEU GLN SEQRES 25 A 341 GLN GLU CYS GLU ALA LEU LEU VAL ASP PHE PRO GLU GLN SEQRES 26 A 341 GLU LYS GLU LEU ARG GLU LEU SER ALA TRP MET ALA GLY SEQRES 27 A 341 ALA VAL ARG SEQRES 1 B 341 GLY SER HIS MET SER THR LEU ARG LEU LEU ILE SER ASP SEQRES 2 B 341 SER TYR ASP PRO TRP PHE ASN LEU ALA VAL ALA GLU CYS SEQRES 3 B 341 ILE PHE ARG GLN MET PRO ALA THR GLN ARG VAL LEU PHE SEQRES 4 B 341 LEU TRP ARG ASN ALA ASP THR VAL VAL ILE GLY ARG ALA SEQRES 5 B 341 GLN ASN PRO TRP LYS GLU CYS ASN THR ARG ARG MET GLU SEQRES 6 B 341 GLU ASP ASN VAL ARG LEU ALA ARG ARG SER SER GLY GLY SEQRES 7 B 341 GLY ALA VAL PHE HIS ASP LEU GLY ASN THR CYS PHE THR SEQRES 8 B 341 PHE MET ALA GLY LYS PRO GLU TYR ASP LYS THR ILE SER SEQRES 9 B 341 THR SER ILE VAL LEU ASN ALA LEU ASN ALA LEU GLY VAL SEQRES 10 B 341 SER ALA GLU ALA SER GLY ARG ASN ASP LEU VAL VAL LYS SEQRES 11 B 341 THR VAL GLU GLY ASP ARG LYS VAL SER GLY SER ALA TYR SEQRES 12 B 341 ARG GLU THR LYS ASP ARG GLY ALA HIS GLY GLY THR LEU SEQRES 13 B 341 LEU LEU ASN ALA ASP LEU SER ARG LEU ALA ASN TYR LEU SEQRES 14 B 341 ASN PRO ASP LYS LYS LYS LEU ALA ALA LYS GLY ILE THR SEQRES 15 B 341 SER VAL ARG SER ARG VAL THR ASN LEU THR GLU LEU LEU SEQRES 16 B 341 PRO GLY ILE THR HIS GLU GLN VAL CYS GLU ALA ILE THR SEQRES 17 B 341 GLU ALA PHE PHE ALA HIS TYR GLY GLU ARG VAL GLU ALA SEQRES 18 B 341 GLU ILE ILE SER PRO ASN LYS THR PRO ASP LEU PRO ASN SEQRES 19 B 341 PHE ALA GLU THR PHE ALA ARG GLN SER SER TRP GLU TRP SEQRES 20 B 341 ASN PHE GLY GLN ALA PRO ALA PHE SER HIS LEU LEU ASP SEQRES 21 B 341 GLU ARG PHE THR TRP GLY GLY VAL GLU LEU HIS PHE ASP SEQRES 22 B 341 VAL GLU LYS GLY HIS ILE THR ARG ALA GLN VAL PHE THR SEQRES 23 B 341 ASP SER LEU ASN PRO ALA PRO LEU GLU ALA LEU ALA GLY SEQRES 24 B 341 ARG LEU GLN GLY CYS LEU TYR ARG ALA ASP MET LEU GLN SEQRES 25 B 341 GLN GLU CYS GLU ALA LEU LEU VAL ASP PHE PRO GLU GLN SEQRES 26 B 341 GLU LYS GLU LEU ARG GLU LEU SER ALA TRP MET ALA GLY SEQRES 27 B 341 ALA VAL ARG HET 37R A 401 39 HET 37R A 402 29 HET 37R B 401 29 HET 37R B 402 39 HETNAM 37R 5-(3,7-DIHYDROXY-10H-PHENOXAZIN-2-YL)PENTANAMIDE FORMUL 3 37R 4(C17 H18 N2 O4) FORMUL 7 HOH *161(H2 O) HELIX 1 AA1 ASP A 12 GLN A 26 1 15 HELIX 2 AA2 ASN A 50 CYS A 55 1 6 HELIX 3 AA3 ASN A 56 ASP A 63 1 8 HELIX 4 AA4 ASP A 96 GLY A 112 1 17 HELIX 5 AA5 SER A 159 TYR A 164 1 6 HELIX 6 AA6 ASP A 168 ALA A 173 1 6 HELIX 7 AA7 ASN A 186 LEU A 191 1 6 HELIX 8 AA8 THR A 195 GLY A 212 1 18 HELIX 9 AA9 ASN A 230 SER A 239 1 10 HELIX 10 AB1 SER A 240 PHE A 245 1 6 HELIX 11 AB2 PRO A 287 GLN A 298 1 12 HELIX 12 AB3 ARG A 303 ALA A 313 1 11 HELIX 13 AB4 PHE A 318 GLU A 320 5 3 HELIX 14 AB5 GLN A 321 VAL A 336 1 16 HELIX 15 AB6 ASP B 12 GLN B 26 1 15 HELIX 16 AB7 ASN B 50 CYS B 55 1 6 HELIX 17 AB8 ASN B 56 ASP B 63 1 8 HELIX 18 AB9 ASP B 96 GLY B 112 1 17 HELIX 19 AC1 ARG B 160 LEU B 165 1 6 HELIX 20 AC2 ASN B 186 LEU B 190 5 5 HELIX 21 AC3 THR B 195 GLY B 212 1 18 HELIX 22 AC4 ASN B 230 SER B 239 1 10 HELIX 23 AC5 SER B 240 PHE B 245 1 6 HELIX 24 AC6 PRO B 287 GLN B 298 1 12 HELIX 25 AC7 ARG B 303 CYS B 311 1 9 HELIX 26 AC8 PHE B 318 GLU B 320 5 3 HELIX 27 AC9 GLN B 321 VAL B 336 1 16 SHEET 1 AA1 8 ALA A 115 SER A 118 0 SHEET 2 AA1 8 ASP A 122 VAL A 125 -1 O VAL A 124 N GLU A 116 SHEET 3 AA1 8 ARG A 132 GLU A 141 -1 O ARG A 132 N VAL A 125 SHEET 4 AA1 8 ARG A 145 LEU A 153 -1 O ALA A 147 N ARG A 140 SHEET 5 AA1 8 ASN A 83 GLY A 91 -1 N PHE A 88 O HIS A 148 SHEET 6 AA1 8 ARG A 32 TRP A 37 -1 N TRP A 37 O CYS A 85 SHEET 7 AA1 8 LEU A 3 SER A 8 1 N LEU A 6 O LEU A 34 SHEET 8 AA1 8 ALA A 217 ILE A 220 1 O GLU A 218 N LEU A 5 SHEET 1 AA2 3 ARG A 66 ARG A 69 0 SHEET 2 AA2 3 THR A 42 ILE A 45 1 N VAL A 43 O ALA A 68 SHEET 3 AA2 3 VAL A 77 HIS A 79 -1 O HIS A 79 N THR A 42 SHEET 1 AA3 3 HIS A 253 PHE A 259 0 SHEET 2 AA3 3 GLY A 262 GLU A 271 -1 O LEU A 266 N LEU A 255 SHEET 3 AA3 3 HIS A 274 THR A 282 -1 O HIS A 274 N GLU A 271 SHEET 1 AA4 8 ALA B 115 SER B 118 0 SHEET 2 AA4 8 ASP B 122 VAL B 125 -1 O VAL B 124 N GLU B 116 SHEET 3 AA4 8 ARG B 132 GLU B 141 -1 O ARG B 132 N VAL B 125 SHEET 4 AA4 8 ARG B 145 LEU B 153 -1 O ALA B 147 N ARG B 140 SHEET 5 AA4 8 ASN B 83 GLY B 91 -1 N PHE B 88 O HIS B 148 SHEET 6 AA4 8 ARG B 32 TRP B 37 -1 N TRP B 37 O CYS B 85 SHEET 7 AA4 8 LEU B 3 SER B 8 1 N LEU B 6 O LEU B 34 SHEET 8 AA4 8 GLU B 218 ILE B 220 1 O GLU B 218 N LEU B 5 SHEET 1 AA5 3 ARG B 66 ARG B 69 0 SHEET 2 AA5 3 THR B 42 ILE B 45 1 N VAL B 43 O ALA B 68 SHEET 3 AA5 3 VAL B 77 HIS B 79 -1 O VAL B 77 N VAL B 44 SHEET 1 AA6 3 HIS B 253 PHE B 259 0 SHEET 2 AA6 3 GLY B 262 GLU B 271 -1 O LEU B 266 N LEU B 255 SHEET 3 AA6 3 HIS B 274 THR B 282 -1 O GLN B 279 N HIS B 267 CISPEP 1 LYS A 92 PRO A 93 0 0.33 CISPEP 2 LYS B 92 PRO B 93 0 -1.53 SITE 1 AC1 8 LEU A 17 ARG A 70 SER A 72 GLY A 74 SITE 2 AC1 8 GLY A 75 HIS A 79 ALA A 138 37R A 402 SITE 1 AC2 7 VAL A 77 HIS A 79 GLY A 149 GLY A 150 SITE 2 AC2 7 THR A 151 37R A 401 HOH A 531 SITE 1 AC3 6 SER B 137 ALA B 138 GLY B 149 GLY B 150 SITE 2 AC3 6 THR B 151 37R B 402 SITE 1 AC4 8 LEU B 17 ARG B 70 SER B 72 GLY B 75 SITE 2 AC4 8 VAL B 77 HIS B 79 ALA B 138 37R B 401 CRYST1 79.117 89.951 108.890 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012640 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011117 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009184 0.00000